Methylbenzylpiperazine

From Self-sufficiency
Jump to: navigation, search
Methylbenzylpiperazine
140px
140px
Systematic (IUPAC) name
1-benzyl-4-methylpiperazine
Clinical data
Routes of
administration
oral
Pharmacokinetic data
Metabolism hepatic
Excretion renal
Identifiers
CAS Number 374898-00-7
PubChem CID 763557
Synonyms 1-methyl-4-(phenylmethyl)piperazine; 1-methyl-4-benzylpiperazine
Chemical data
Formula C12H18N2
Molar mass 190.294 g/mol[[Script error: No such module "String".]]
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

MBZP (1-methyl-4-benzylpiperazine) is a stimulant drug which is a derivative of benzylpiperazine. MBZP has been sold as an ingredient in legal recreational drugs known as "Party pills", initially in New Zealand and subsequently in other countries around the world.

The effects of MBZP are very similar to those of BZP, but the stimulant effect is slightly weaker and it seems to have less of a tendency to cause negative side effects such as headaches and nausea.[citation needed]

Based on the recommendation of the EACD, the New Zealand government has passed legislation which placed BZP, along with the other piperazine derivatives TFMPP, mCPP, pFPP, MeOPP and MBZP, into Class C of the New Zealand Misuse of Drugs Act 1975. A ban was intended to come into effect in New Zealand on December 18, 2007, but the law change did not go through until the following year, and the sale of BZP and the other listed piperazines became illegal in New Zealand as of 1 April 2008. An amnesty for possession and usage of these drugs will remain until October 2008, at which point they will become completely illegal.[1]

See also

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

  1. Misuse of Drugs (Classification of BZP) Amendment Bill 2008